The future of stem cells in ophthalmology

blefaritis tratamiento barcelona

In recent years, research into the use of stem cells in various degenerative eye diseases has expanded. Currently, there are more than 10 examples of collaborations between the biomedical industry and medical institutions conducting studies using different types of stem cells for the treatment of certain eye diseases, in some cases with human trials. What are stem cells? Every organ and tissue in our body is made up of specialized cells that originally come from a group of stem cells in the early stages of the embryo. As adults, however, we only have stem cells in certain areas of the body to regenerate organs and tissues that are injured or lost, such as our skin, hair, blood, and the lining of our intestines. Stem cells are like a blank microchip that can be programmed to perform very specific and specialized tasks. Under the right conditions, stem cells develop or differentiate into specialized cells that carry out a specific function, such as skin, muscle, liver, etc. Furthermore, stem cells can grow and multiply without differentiating, giving rise to more stem cells. These two characteristics of pluripotency and self-renewal distinguish these cells from other cells in the body and therefore hold great therapeutic promise for a wide range of degenerative diseases. Possible Applications in Ophthalmology There are several types of stem cells used in research, primarily embryonic stem cells, adult stem cells, and induced pluripotent stem cells. In the field of ophthalmology, their future use is being investigated primarily for degenerative retinal diseases. Among these diseases is macular degeneration, which is the most common cause of vision loss in people over 65 in developed countries. The loss of retinal cells in this disease causes a decrease in the patient’s central vision, which in many cases is severe and irreversible. Although much progress has been made in the treatment of certain forms of this disease, the atrophic type currently has no effective treatment. Clinical trials, even with small numbers of patients, have already demonstrated some benefit in the treatment of macular degeneration and Stargardt disease (another macular disease) in humans. Other retinal diseases that could benefit from these treatments are diabetic retinopathy, retinitis pigmentosa, and retinopathy of prematurity. On the other hand, there are two other fields of ophthalmology in which stem cell research promises to be beneficial: the cornea and glaucoma. In populated countries like India, China, and emerging economies, blindness due to corneal problems is common, and the availability of donor corneas for transplantation is very limited, so the use of stem cells to regenerate these tissues can be very useful. Glaucoma, on the other hand, is a degenerative disease of the optic nerve that causes progressive and irreversible vision loss. There are also very preliminary studies investigating the possible application of this therapy for these patients. It would be fantastic if all our body parts could come with a lifetime warranty and could be replaced when they stopped working. Well, perhaps stem cells could do that for us one day.

Dr. José Nieto

Dr. Nieto is exclusively dedicated to oculoplastic surgery. He combines his reconstructive surgical work in public healthcare with his private practice in both reconstructive and cosmetic procedures.